Logo image of ALVIN.PA

VINPAI SAS (ALVIN.PA) Stock Fundamental Analysis

EPA:ALVIN - Euronext Paris - Matif - FR001400AXT1 - Common Stock - Currency: EUR

3.5  +0.06 (+1.74%)

Fundamental Rating

2

Overall ALVIN gets a fundamental rating of 2 out of 10. We evaluated ALVIN against 69 industry peers in the Chemicals industry. ALVIN may be in some trouble as it scores bad on both profitability and health. ALVIN is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALVIN had negative earnings in the past year.
ALVIN had a negative operating cash flow in the past year.
ALVIN had negative earnings in each of the past 5 years.
ALVIN had a negative operating cash flow in each of the past 5 years.
ALVIN.PA Yearly Net Income VS EBIT VS OCF VS FCFALVIN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -38.79%, ALVIN is not doing good in the industry: 91.30% of the companies in the same industry are doing better.
ALVIN's Return On Equity of -423.10% is on the low side compared to the rest of the industry. ALVIN is outperformed by 94.20% of its industry peers.
Industry RankSector Rank
ROA -38.79%
ROE -423.1%
ROIC N/A
ROA(3y)-27.48%
ROA(5y)-20.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALVIN.PA Yearly ROA, ROE, ROICALVIN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600 -600

1.3 Margins

ALVIN has a worse Gross Margin (9.75%) than 78.26% of its industry peers.
ALVIN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALVIN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.19%
GM growth 5Y-20.18%
ALVIN.PA Yearly Profit, Operating, Gross MarginsALVIN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

ALVIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALVIN has more shares outstanding than it did 1 year ago.
ALVIN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALVIN has a worse debt to assets ratio.
ALVIN.PA Yearly Shares OutstandingALVIN.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALVIN.PA Yearly Total Debt VS Total AssetsALVIN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

ALVIN has an Altman-Z score of -0.01. This is a bad value and indicates that ALVIN is not financially healthy and even has some risk of bankruptcy.
ALVIN's Altman-Z score of -0.01 is on the low side compared to the rest of the industry. ALVIN is outperformed by 86.96% of its industry peers.
ALVIN has a Debt/Equity ratio of 4.18. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 4.18, ALVIN is not doing good in the industry: 92.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.18
Debt/FCF N/A
Altman-Z -0.01
ROIC/WACCN/A
WACC6.92%
ALVIN.PA Yearly LT Debt VS Equity VS FCFALVIN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 0.67 indicates that ALVIN may have some problems paying its short term obligations.
With a Current ratio value of 0.67, ALVIN is not doing good in the industry: 91.30% of the companies in the same industry are doing better.
ALVIN has a Quick Ratio of 0.67. This is a bad value and indicates that ALVIN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.44, ALVIN is doing worse than 91.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.44
ALVIN.PA Yearly Current Assets VS Current LiabilitesALVIN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

7

3. Growth

3.1 Past

ALVIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.14%, which is quite impressive.
The Revenue has grown by 15.90% in the past year. This is quite good.
The Revenue has been growing by 65.39% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)23.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.06%
Revenue 1Y (TTM)15.9%
Revenue growth 3Y21.3%
Revenue growth 5Y65.39%
Sales Q2Q%13.17%

3.2 Future

Based on estimates for the next years, ALVIN will show a very strong growth in Earnings Per Share. The EPS will grow by 97.18% on average per year.
ALVIN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.45% yearly.
EPS Next Y350%
EPS Next 2Y141.52%
EPS Next 3Y97.18%
EPS Next 5YN/A
Revenue Next Year33.7%
Revenue Next 2Y31.88%
Revenue Next 3Y26.45%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALVIN.PA Yearly Revenue VS EstimatesALVIN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
ALVIN.PA Yearly EPS VS EstimatesALVIN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.1 0.2 0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALVIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 22.65, ALVIN is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as ALVIN.
ALVIN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE N/A
Fwd PE 22.65
ALVIN.PA Price Earnings VS Forward Price EarningsALVIN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALVIN.PA Per share dataALVIN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALVIN's earnings are expected to grow with 97.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y141.52%
EPS Next 3Y97.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALVIN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VINPAI SAS

EPA:ALVIN (6/18/2025, 7:00:00 PM)

3.5

+0.06 (+1.74%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners46.38%
Ins Owner ChangeN/A
Market Cap12.11M
Analysts40
Price Target4.59 (31.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.65
P/S 1.4
P/FCF N/A
P/OCF N/A
P/B 13.05
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.87
EYN/A
EPS(NY)0.15
Fwd EY4.41%
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-1.02
OCFYN/A
SpS2.5
BVpS0.27
TBVpS-0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.79%
ROE -423.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.75%
FCFM N/A
ROA(3y)-27.48%
ROA(5y)-20.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.19%
GM growth 5Y-20.18%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 4.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.24%
Cap/Sales 2.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.44
Altman-Z -0.01
F-Score3
WACC6.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.06%
EPS Next Y350%
EPS Next 2Y141.52%
EPS Next 3Y97.18%
EPS Next 5YN/A
Revenue 1Y (TTM)15.9%
Revenue growth 3Y21.3%
Revenue growth 5Y65.39%
Sales Q2Q%13.17%
Revenue Next Year33.7%
Revenue Next 2Y31.88%
Revenue Next 3Y26.45%
Revenue Next 5YN/A
EBIT growth 1Y-70.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.79%
EBIT Next 3Y38.5%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A